Mylan and federal investigators Thursday finalized a $465 million settlement of charges the drugmaker overcharged the government for the injection allergy medication EpiPen. Resolving an issue that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback